BCL7A Antikörper (Internal Region)
-
- Target Alle BCL7A Antikörper anzeigen
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL7A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- BCL7A antibody detects endogenous levels of total BCL7A protein.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- The antiserum was produced against synthesized peptide derived from internal of human BCL7A.
- Top Product
- Discover our top product BCL7A Primärantikörper
-
anti-B-Cell CLL/lymphoma 7A (BCL7A) (C-Term) antibody
BCL7A Reaktivität: Human, Maus, Ratte WB, ICC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (C-Term) antibodyVerified BCL7A Reaktivität: Human WB, ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (Middle Region) antibodyBCL7A Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Schwein, Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 1-210) antibodyBCL7A Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 1-30), (N-Term) antibodyBCL7A Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB24969 unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (C-Term) antibodyBCL7A Reaktivität: Human, Maus WB, ELISA, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 107-156) antibodyBCL7A Reaktivität: Human, Affe, Fledermaus WB Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 71-120) antibodyBCL7A Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Schwein, Meerschweinchen, Pferd, Kaninchen, Affe, Zebrafisch (Danio rerio), Huhn WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C / 1 year
- Haltbarkeit
- 12 months
-
- Target
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
- Andere Bezeichnung
- BCL7A (BCL7A Produkte)
- Synonyme
- BCL7 antikoerper, cb585 antikoerper, id:ibd1097 antikoerper, sb:cb585 antikoerper, wu:fk02d01 antikoerper, zgc:92023 antikoerper, 4432415N06Rik antikoerper, AI448316 antikoerper, bcl7a antikoerper, MGC89576 antikoerper, BCL7A antikoerper, BCL tumor suppressor 7A antikoerper, B-cell CLL/lymphoma 7A antikoerper, B cell CLL/lymphoma 7A antikoerper, B-cell CLL/lymphoma 7A L homeolog antikoerper, BCL7A antikoerper, bcl7a antikoerper, Bcl7a antikoerper, bcl7a.L antikoerper
- Hintergrund
- B-cell CLL/lymphoma 7 family member A, B-cell CLL/lymphoma 7A, B-cell CLL/lymphoma-7, BCL7, BCL7A
- UniProt
- Q4VC05
-
